Effect on perfusion chamber thrombus size in patients with atrial fibrillation during anticoagulant treatment with oral direct thrombin inhibitors, AZD0837 or ximelagatran, or with vitamin K antagonists-Reference-Cited by-同舟云学术

Effect on perfusion chamber thrombus size in patients with atrial fibrillation during anticoagulant treatment with oral direct thrombin inhibitors, AZD0837 or ximelagatran, or with vitamin K antagonists

Published:2012-04 Issue:4 Volume:129 Page:e83-e91
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Wolzt Michael,Eriksson Ulf G.,Gouya Ghazaleh,Leuchten Nicolai,Kapiotis Stylianos,Elg Margareta,Schützer Kajs-Marie,Zetterstrand Sofia,Holmberg Malin,Wåhlander Karin

Publisher

Elsevier BV

Subject

Hematology

Reference23 articles.

1. Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor Xa inhibitors in development;Eriksson;Clin Pharmacokinet,2009

2. The Yin-Yang of thrombin and activated protein C;Dutt;Br J Haematol,2008

3. Factor Xa or thrombin: is thrombin a better target?;Weitz;J Thromb Haemost,2007

4. Single-dose pharmacokinetics, pharmacodynamics and safety of AZD0837, a novel oral direct thrombin inhibitor, in young healthy male subjects;Johansson;Int J Clin Pharmacol Therap,2011

5. Biochemical and pharmacological effects of the direct thrombin inhibitor AR-H067637;Deinum;Thromb Haemost,2009

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of pre-admission treatment with non-vitamin K oral anticoagulants on stroke severity in patients with acute ischemic stroke;Journal of Thrombosis and Thrombolysis;2018-02-23

2. The effect of a dual or a triple antithrombotic therapy with apixaban on thrombus formation in vivo and in an ex vivo perfusion chamber model;Medicine;2016-07

3. Latest developments in anticoagulant drug discovery;Drug Discovery Today;2014-07

4. Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework;Nature Reviews Drug Discovery;2014-05-16

5. Open-label, randomized study of the effect of rivaroxaban with or without acetylsalicylic acid on thrombus formation in a perfusion chamber;Thrombosis Research;2013-08